{
  "disease_name": "Familial chylomicronemia syndrome",
  "orpha_code": "444490",
  "drugs": [
    {
      "name": "WAYLIVRA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/556976?name=444490&mode=orpha&region=",
      "regulatory_id": "556976",
      "orpha_substance_code": "ORPHA:444490",
      "details": [
        "WAYLIVRA(Tradename                        - 03/05/2019)Disease(s) concernedORPHA:444490 Familial chylomicronemia syndrome",
        "WAYLIVRA(Tradename                        - 03/05/2019)",
        "(Tradename                        - 03/05/2019)",
        "Disease(s) concernedORPHA:444490 Familial chylomicronemia syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/556969?name=444490&mode=orpha&region=&status=all",
          "text": "WAYLIVRA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/444490",
          "text": "ORPHA:444490 Familial chylomicronemia syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/556976?name=444490&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Olezarsen",
      "substance_url": "/en/drug/substance/622060?name=444490&mode=orpha&region=&status=all",
      "substance_id": "622060",
      "regulatory_url": "/en/drug/regulatory/686872?name=444490&mode=orpha&region=",
      "regulatory_id": "686872",
      "orpha_substance_code": "ORPHA:444490",
      "details": [
        "Olezarsen(Medicinal product                        - 21/08/2024)Disease(s) concernedORPHA:444490 Familial chylomicronemia syndrome",
        "Olezarsen(Medicinal product                        - 21/08/2024)",
        "(Medicinal product                        - 21/08/2024)",
        "Disease(s) concernedORPHA:444490 Familial chylomicronemia syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/622060?name=444490&mode=orpha&region=&status=all",
          "text": "Olezarsen",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/444490",
          "text": "ORPHA:444490 Familial chylomicronemia syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/686872?name=444490&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Synthetic double-stranded siRNA oligonucleotide directed against apolipoprotein C-III mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues",
      "substance_url": "/en/drug/substance/627673?name=444490&mode=orpha&region=&status=all",
      "substance_id": "627673",
      "regulatory_url": "/en/drug/regulatory/627674?name=444490&mode=orpha&region=",
      "regulatory_id": "627674",
      "orpha_substance_code": "ORPHA:444490",
      "details": [
        "Synthetic double-stranded siRNA oligonucleotide directed against apolipoprotein C-III mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues(Medicinal product                        - 19/07/2021)Disease(s) concernedORPHA:444490 Familial chylomicronemia syndrome",
        "Synthetic double-stranded siRNA oligonucleotide directed against apolipoprotein C-III mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues(Medicinal product                        - 19/07/2021)",
        "(Medicinal product                        - 19/07/2021)",
        "Disease(s) concernedORPHA:444490 Familial chylomicronemia syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/627673?name=444490&mode=orpha&region=&status=all",
          "text": "Synthetic double-stranded siRNA oligonucleotide directed against apolipoprotein C-III mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/444490",
          "text": "ORPHA:444490 Familial chylomicronemia syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/627674?name=444490&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Apolipotrotein C-III antisense oligonucleotide",
      "substance_url": "/en/drug/substance/376872?name=444490&mode=orpha&region=&status=all",
      "substance_id": "376872",
      "regulatory_url": "/en/drug/regulatory/397921?name=444490&mode=orpha&region=",
      "regulatory_id": "397921",
      "orpha_substance_code": "ORPHA:444490",
      "details": [
        "Apolipotrotein C-III antisense oligonucleotide(Medicinal product                        - 19/02/2014)Disease(s) concernedORPHA:444490 Familial chylomicronemia syndrome",
        "Apolipotrotein C-III antisense oligonucleotide(Medicinal product                        - 19/02/2014)",
        "(Medicinal product                        - 19/02/2014)",
        "Disease(s) concernedORPHA:444490 Familial chylomicronemia syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/376872?name=444490&mode=orpha&region=&status=all",
          "text": "Apolipotrotein C-III antisense oligonucleotide",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/444490",
          "text": "ORPHA:444490 Familial chylomicronemia syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/397921?name=444490&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Lomitapide",
      "substance_url": "/en/drug/substance/240492?name=444490&mode=orpha&region=&status=all",
      "substance_id": "240492",
      "regulatory_url": "/en/drug/regulatory/260317?name=444490&mode=orpha&region=",
      "regulatory_id": "260317",
      "orpha_substance_code": "ORPHA:444490",
      "details": [
        "Lomitapide(Medicinal product                        - 17/12/2010)Disease(s) concernedORPHA:444490 Familial chylomicronemia syndrome",
        "Lomitapide(Medicinal product                        - 17/12/2010)",
        "(Medicinal product                        - 17/12/2010)",
        "Disease(s) concernedORPHA:444490 Familial chylomicronemia syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/240492?name=444490&mode=orpha&region=&status=all",
          "text": "Lomitapide",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/444490",
          "text": "ORPHA:444490 Familial chylomicronemia syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/260317?name=444490&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Trans-4-[4-[5-[[6-(trifluoromethyl)-3-pyridinyl]amino]-2-pyridinyl]phenyl] cyclohexane acetic acid sodium salt",
      "substance_url": "/en/drug/substance/317205?name=444490&mode=orpha&region=&status=all",
      "substance_id": "317205",
      "regulatory_url": "/en/drug/regulatory/360541?name=444490&mode=orpha&region=",
      "regulatory_id": "360541",
      "orpha_substance_code": "ORPHA:444490",
      "details": [
        "Trans-4-[4-[5-[[6-(trifluoromethyl)-3-pyridinyl]amino]-2-pyridinyl]phenyl] cyclohexane acetic acid sodium salt(Medicinal product                        - 14/09/2013)Disease(s) concernedORPHA:444490 Familial chylomicronemia syndrome",
        "Trans-4-[4-[5-[[6-(trifluoromethyl)-3-pyridinyl]amino]-2-pyridinyl]phenyl] cyclohexane acetic acid sodium salt(Medicinal product                        - 14/09/2013)",
        "(Medicinal product                        - 14/09/2013)",
        "Disease(s) concernedORPHA:444490 Familial chylomicronemia syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/317205?name=444490&mode=orpha&region=&status=all",
          "text": "Trans-4-[4-[5-[[6-(trifluoromethyl)-3-pyridinyl]amino]-2-pyridinyl]phenyl] cyclohexane acetic acid sodium salt",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/444490",
          "text": "ORPHA:444490 Familial chylomicronemia syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/360541?name=444490&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "TRYNGOLZA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/692505?name=444490&mode=orpha&region=",
      "regulatory_id": "692505",
      "orpha_substance_code": "ORPHA:444490",
      "details": [
        "TRYNGOLZA(Tradename                        - 19/12/2024)Disease(s) concernedORPHA:444490 Familial chylomicronemia syndrome",
        "TRYNGOLZA(Tradename                        - 19/12/2024)",
        "(Tradename                        - 19/12/2024)",
        "Disease(s) concernedORPHA:444490 Familial chylomicronemia syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/692409?name=444490&mode=orpha&region=&status=all",
          "text": "TRYNGOLZA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/444490",
          "text": "ORPHA:444490 Familial chylomicronemia syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/692505?name=444490&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Olezarsen",
      "substance_url": "/en/drug/substance/622060?name=444490&mode=orpha&region=&status=all",
      "substance_id": "622060",
      "regulatory_url": "/en/drug/regulatory/662832?name=444490&mode=orpha&region=",
      "regulatory_id": "662832",
      "orpha_substance_code": "ORPHA:444490",
      "details": [
        "Olezarsen(Medicinal product                        - 14/02/2024)Disease(s) concernedORPHA:444490 Familial chylomicronemia syndrome",
        "Olezarsen(Medicinal product                        - 14/02/2024)",
        "(Medicinal product                        - 14/02/2024)",
        "Disease(s) concernedORPHA:444490 Familial chylomicronemia syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/622060?name=444490&mode=orpha&region=&status=all",
          "text": "Olezarsen",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/444490",
          "text": "ORPHA:444490 Familial chylomicronemia syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/662832?name=444490&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "GLYBERA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/352359?name=444490&mode=orpha&region=",
      "regulatory_id": "352359",
      "orpha_substance_code": "ORPHA:309015",
      "details": [
        "GLYBERA(Tradename                        - 25/10/2012)Disease(s) concernedORPHA:309015 Familial lipoprotein lipase deficiency",
        "GLYBERA(Tradename                        - 25/10/2012)",
        "(Tradename                        - 25/10/2012)",
        "Disease(s) concernedORPHA:309015 Familial lipoprotein lipase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/352356?name=444490&mode=orpha&region=&status=all",
          "text": "GLYBERA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/309015",
          "text": "ORPHA:309015 Familial lipoprotein lipase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/352359?name=444490&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Alipogene tiparvovec",
      "substance_url": "/en/drug/substance/82361?name=444490&mode=orpha&region=&status=all",
      "substance_id": "82361",
      "regulatory_url": "/en/drug/regulatory/133874?name=444490&mode=orpha&region=",
      "regulatory_id": "133874",
      "orpha_substance_code": "ORPHA:309015",
      "details": [
        "Alipogene tiparvovec(Medicinal product                        - 08/03/2004)Disease(s) concernedORPHA:309015 Familial lipoprotein lipase deficiency",
        "Alipogene tiparvovec(Medicinal product                        - 08/03/2004)",
        "(Medicinal product                        - 08/03/2004)",
        "Disease(s) concernedORPHA:309015 Familial lipoprotein lipase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/82361?name=444490&mode=orpha&region=&status=all",
          "text": "Alipogene tiparvovec",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/309015",
          "text": "ORPHA:309015 Familial lipoprotein lipase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/133874?name=444490&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:04:13.175238",
  "run_number": 1,
  "total_drugs_found": 10,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Familial+chylomicronemia+syndrome&orphaCode=444490&name=444490&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Familial chylomicronemia syndrome",
    "orphaCode": "444490",
    "name": "444490",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}